Xenon Pharmaceuticals Inc — 四半期キャッシュフロー (NASDAQ:XENE) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 798.14 M743.28 M674.28 M607.84 M633.16 M 負債合計 43.24 M39.32 M40.3 M48.33 M51.4 M 純資産合計 754.9 M703.96 M633.98 M559.51 M581.76 M 負債および純資産合計 798.14 M743.28 M674.28 M607.84 M633.16 M 有利子負債合計 ————— 純負債 —————

ニュース

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

Wedbush、Xenon Pharmaceuticalsの目標株価を63ドルに引き下げ

Wedbush lowers Xenon Pharmaceuticals stock price target to $63

BofA、臨床試験成功を受けてXenon Pharmaceuticalsの目標株価を引き上げ

BofA raises Xenon Pharmaceuticals price target on trial success

Xenon Pharmaceuticalsが7億4750万ドルの公募増資を完了

Xenon Pharmaceuticals closes $747.5M public offering

Xenon Pharmaceuticalsが1株57ドルで6億5000万ドルの公募増資を実施

Xenon Pharmaceuticals prices $650M public offering at $57/share

XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study

Citizens、発作治療薬の可能性を評価しRapport Therapeutics株の投資判断を据え置き

Citizens reiterates Rapport Therapeutics stock rating on seizure drug potential